Subscribe to RSS
DOI: 10.1055/s-0044-1786999
Polymicrogyria, Cobblestone Malformations, and Tubulin Mutation (Overmigration beyond Pial Limiting Membrane): Diagnosis, Treatment, and Rehabilitation Approach
Abstract
Polymicrogyria, cobblestone malformations, and tubulinopathies constitute a group of neuronal migration abnormalities beyond the pial limiting membrane. Their etiopathogenesis remains unclear, with proposed environmental and genetic factors, including copy number variations and single-gene disorders, recently categorized.
Polymicrogyria features numerous small circumvolutions separated by large, shallow grooves, often affecting the perisylvian cortex with various presentations. Clinical manifestations vary depending on lesion degree, extent, and location, commonly including epilepsy, encephalopathies, spastic tetraparesis, mental retardation, and cortical function deficits.
Cobblestone malformations exhibit a Roman-like pavement cortex, affecting both hemispheres symmetrically due to disruption of the glia limitans, frequently linked to glycosyltransferase gene mutations. Classified separately from lissencephaly type II, they are associated with congenital muscular dystrophy syndromes such as Fukuyama congenital muscular dystrophy, Walker–Warburg syndrome, and muscle–eye–brain disease.
Tubulinopathies encompass diverse cerebral malformations resulting from α-tubulin isotype gene variants, exhibiting a wide clinical spectrum including motor/cognitive impairment, facial diplegia, strabismus, and epilepsy.
Diagnosis relies on magnetic resonance imaging (MRI) with age-specific protocols, highlighting the gray–white junction as a polymicrogyria marker, though neonatal diagnosis may be challenging due to technical and brain maturity issues.
To date, no effective treatments are available and management include physiotherapy, speech and language therapy, and vision training program for oculomotor disabilities; antiepileptic drugs are commonly necessary, and most severe forms usually require specific nutritional support.
* These authors have contributed equally to the article.
Publication History
Received: 05 December 2023
Accepted: 04 April 2024
Article published online:
29 May 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology 2005; 65 (12) 1873-1887
- 2 Ruggieri M, Praticò AD, Serra A. et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
- 3 Stutterd CA, Leventer RJ. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am J Med Genet C Semin Med Genet 2014; 166C (02) 227-239
- 4 Falsaperla R, D'Angelo G, Praticò AD. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav 2020; 112: 107361
- 5 Barkovich AJ, Kjos BO. Schizencephaly: correlation of clinical findings with MR characteristics. AJNR Am J Neuroradiol 1992; 13 (01) 85-94
- 6 Pavone P, Briuglia S, Falsaperla R. et al. Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13. Am J Med Genet A 2014; 164A (07) 1734-1743
- 7 Leventer RJ, Phelan EM, Coleman LT, Kean MJ, Jackson GD, Harvey AS. Clinical and imaging features of cortical malformations in childhood. Neurology 1999; 53 (04) 715-722
- 8 Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36 (07) 1173-1180
- 9 Barkovich AJ. Imaging of the cobblestone lissencephalies. AJNR Am J Neuroradiol 1996; 17 (04) 615-618
- 10 Pavone P, Praticò AD, Ruggieri M. et al. Acquired peripheral neuropathy: a report on 20 children. Int J Immunopathol Pharmacol 2012; 25 (02) 513-517
- 11 Devisme L, Bouchet C, Gonzalès M. et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain 2012; 135 (Pt 2): 469-482
- 12 Pratico AD, Ruggieri M, Falsaperla R, Pavone P. A probable topiramate-induced limbs paraesthesia and rigid fingers flexion. Curr Drug Saf 2018; 13 (02) 131-136
- 13 Clement E, Mercuri E, Godfrey C. et al. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008; 64 (05) 573-582
- 14 Pavone P, Nigro F, Falsaperla R. et al. Hemihydranencephaly: living with half brain dysfunction. Ital J Pediatr 2013; 39: 3
- 15 Brun BN, Mockler SRH, Laubscher KM. et al. Comparison of brain MRI findings with language and motor function in the dystroglycanopathies. Neurology 2017; 88 (07) 623-629
- 16 Pavone P, Praticò AD, Gentile G. et al. A neurocutaneous phenotype with paired hypo- and hyperpigmented macules, microcephaly and stunted growth as prominent features. Eur J Med Genet 2016; 59 (05) 283-289
- 17 Romero DM, Bahi-Buisson N, Francis F. Genetics and mechanisms leading to human cortical malformations. Semin Cell Dev Biol 2018; 76: 33-75
- 18 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Rediagnosing one of Smith's patients (John McCann) with “neuromas tumours” (1849). Neurol Sci 2017; 38 (03) 493-499
- 19 Amrom D, Tanyalçin I, Verhelst H. et al. Polymicrogyria with dysmorphic basal ganglia? Think tubulin!. Clin Genet 2014; 85 (02) 178-183
- 20 Ruggieri M, Polizzi A, Marceca GP, Catanzaro S, Praticò AD, Di Rocco C. Introduction to phacomatoses (neurocutaneous disorders) in childhood. Childs Nerv Syst 2020; 36 (10) 2229-2268
- 21 Jansen AC, Oostra A, Desprechins B. et al. TUBA1A mutations: from isolated lissencephaly to familial polymicrogyria. Neurology 2011; 76 (11) 988-992
- 22 Incorpora G, Pavone P, Castellano-Chiodo D, Praticò AD, Ruggieri M, Pavone L. Gelastic seizures due to hypothalamic hamartoma: rapid resolution after endoscopic tumor disconnection. Neurocase 2013; 19 (05) 458-461
- 23 Raybaud C, Widjaja E. Development and dysgenesis of the cerebral cortex: malformations of cortical development. Neuroimaging Clin N Am 2011; 21 (03) 483-543 , vii
- 24 Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, La Rosa M. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 2012; 18 (40) 5729-5733
- 25 Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014; 13 (07) 710-726
- 26 Palano GM, Praticò AD, Praticò ER. et al. Accidental ethyl alcohol intoxication in a 30-day-old infant. Clinical findings and neurological follow-up [in Italian]. Minerva Pediatr 2007; 59 (03) 275-279
- 27 Volpe JJ, Inder TE, Darras BT. Volpe's Neurology of the Newborn. 6th ed. Elsevier; 2017. Accessed April 18, 2022 at: https://www.elsevier.com/books/volpes-neurology-of-the-newborn/volpe/978-0-323-42876-7
- 28 Fiumara A, Lanzafame G, Arena A. et al. COVID-19 pandemic outbreak and its psychological impact on patients with rare lysosomal diseases. J Clin Med 2020; 9 (09) 2716
- 29 Bahi-Buisson N, Maillard C. Tubulinopathies overview. In: Adam MP, Everman DB, Mirzaa GM. , et al., eds. GeneReviews®. University of Washington, Seattle; 1993. . Accessed August 22, 2022 at: http://www.ncbi.nlm.nih.gov/books/NBK350554/
- 30 Praticò AD, Leonardi S. Immunotherapy for food allergies: a myth or a reality?. Immunotherapy 2015; 7 (02) 147-161
- 31 Jansen AC, Robitaille Y, Honavar M. et al. The histopathology of polymicrogyria: a series of 71 brain autopsy studies. Dev Med Child Neurol 2016; 58 (01) 39-48
- 32 Salafia S, Praticò AD, Pizzo E, Greco F, Di Bella D. Hemiconvulsion-hemiplegia-epilepsy syndrome. Magnetic resonance findings in a 3-year-old boy. Neurol Neurochir Pol 2013; 47 (06) 584-589
- 33 Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 2001; 56 (10) 1265-1272
- 34 Praticò AD, Ruggieri M. COVID-19 vaccination for children: may be necessary for the full eradication of the disease. Pediatr Res 2021; 90 (06) 1102-1103
- 35 Marques Dias MJ, Harmant-van Rijckevorsel G, Landrieu P, Lyon G. Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy. Neuropediatrics 1984; 15 (01) 18-24
- 36 Ruggieri M, Polizzi A, Catanzaro S, Bianco ML, Praticò AD, Di Rocco C. Neurocutaneous melanocytosis (melanosis). Childs Nerv Syst 2020; 36 (10) 2571-2596
- 37 Aicardi J. Aicardi syndrome. Brain Dev 2005; 27 (03) 164-171
- 38 Praticò AD, Mistrello G, La Rosa M. et al. Immunotherapy: a new horizon for egg allergy?. Expert Rev Clin Immunol 2014; 10 (05) 677-686
- 39 Volpe JJ, Adams RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 1972; 20 (03) 175-198
- 40 Praticò AD. COVID-19 pandemic for pediatric health care: disadvantages and opportunities. Pediatr Res 2021; 89 (04) 709-710
- 41 Takashima S, Chan F, Becker LE, Houdou S, Suzuki Y. Cortical cytoarchitectural and immunohistochemical studies on Zellweger syndrome. Brain Dev 1991; 13 (03) 158-162
- 42 Praticò AD, Giallongo A, Arrabito M. et al. SCN2A and its related epileptic phenotypes. J Pediatr Neurol 2023; 21 (03) 173-185
- 43 Inder TE, Huppi PS, Zientara GP. et al. The postmigrational development of polymicrogyria documented by magnetic resonance imaging from 31 weeks' postconceptional age. Ann Neurol 1999; 45 (06) 798-801
- 44 Praticò AD, Falsaperla R, Comella M, Belfiore G, Polizzi A, Ruggieri M. Case report: a gain-of-function of hamartin may lead to a distinct “inverse TSC1-hamartin” phenotype characterized by reduced cell growth. Front Pediatr 2023; 11: 1101026
- 45 Bankl H, Jellinger K. Central nervous system injuries following fetal carbon monoxide poisoning [in German]. Beitr Pathol Anat 1967; 135 (03) 350-376
- 46 Trifiletti RR, Incorpora G, Polizzi A, Cocuzza MD, Bolan EA, Parano E. Aicardi syndrome with multiple tumors: a case report with literature review. Brain Dev 1995; 17 (04) 283-285
- 47 Golden JA, Harding BN. Cortical malformations: unfolding polymicrogyria. Nat Rev Neurol 2010; 6 (09) 471-472
- 48 Polizzi A, Pavone P, Parano E, Incorpora G, Ruggieri M. Lack of progression of brain atrophy in Aicardi-Goutières syndrome. Pediatr Neurol 2001; 24 (04) 300-302
- 49 Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA. Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol 2011; 70 (06) 438-443
- 50 Leuzzi V, Mastrangelo M, Polizzi A. et al. Report of two never treated adult sisters with aromatic L-amino acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?. JIMD Rep 2015; 15: 39-45
- 51 Barth PG. Disorders of neuronal migration. Can J Neurol Sci 1987; 14 (01) 1-16
- 52 Ruggieri M, Polizzi A. From Aldrovandi's “Homuncio” (1592) to Buffon's girl (1749) and the “Wart Man” of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?. J Med Genet 2003; 40 (03) 227-232
- 53 Parrini E, Conti V, Dobyns WB, Guerrini R. Genetic basis of brain malformations. Mol Syndromol 2016; 7 (04) 220-233
- 54 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor”. Am J Med Genet A 2003; 120A (01) 110-116
- 55 Moser HW. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture. Neurology 1988; 38 (10) 1617-1627
- 56 Ruggieri M, Milone P, Pavone P. et al. Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients. Am J Med Genet A 2012; 158A (11) 2870-2880
- 57 Guerrini R, Filippi T. Neuronal migration disorders, genetics, and epileptogenesis. J Child Neurol 2005; 20 (04) 287-299
- 58 Ruggieri M, Iannetti P, Clementi M. et al. Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 2009; 25 (02) 211-216
- 59 Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J, Martinez V, Palencia R. Unilateral polymicrogyria: a common cause of hemiplegia of prenatal origin. Brain Dev 2001; 23 (04) 216-222
- 60 Pavone P, Praticò AD, Pavone V. et al. Ataxia in children: early recognition and clinical evaluation. Ital J Pediatr 2017; 43 (01) 6
- 61 Dixon-Salazar T, Silhavy JL, Marsh SE. et al. Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am J Hum Genet 2004; 75 (06) 979-987
- 62 Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101 (02) 178-180
- 63 Wieck G, Leventer RJ, Squier WM. et al. Periventricular nodular heterotopia with overlying polymicrogyria. Brain 2005; 128 (Pt 12): 2811-2821
- 64 Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 1998; 79 (05) 423-426
- 65 Jamuar SS, Lam ATN, Kircher M. et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014; 371 (08) 733-743
- 66 Ruggieri M, Huson SM. The neurofibromatoses. An overview. Ital J Neurol Sci 1999; 20 (02) 89-108
- 67 Guerreiro MM, Andermann E, Guerrini R. et al. Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol 2000; 48 (01) 39-48
- 68 Pratico AD, Longo L, Mansueto S. et al. Off-label use of drugs and adverse drug reactions in pediatric units: a prospective, multicenter study. Curr Drug Saf 2018; 13 (03) 200-207
- 69 Chang BS, Piao X, Bodell A. et al. Bilateral frontoparietal polymicrogyria: clinical and radiological features in 10 families with linkage to chromosome 16. Ann Neurol 2003; 53 (05) 596-606
- 70 Ruggieri M. Cutis tricolor: congenital hyper- and hypopigmented lesions in a background of normal skin with and without associated systemic features: further expansion of the phenotype. Eur J Pediatr 2000; 159 (10) 745-749
- 71 Piao X, Basel-Vanagaite L, Straussberg R. et al. An autosomal recessive form of bilateral frontoparietal polymicrogyria maps to chromosome 16q12.2-21. Am J Hum Genet 2002; 70 (04) 1028-1033
- 72 Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998; 101 (1 Pt 1): 112-119
- 73 Chang BS, Piao X, Giannini C. et al. Bilateral generalized polymicrogyria (BGP): a distinct syndrome of cortical malformation. Neurology 2004; 62 (10) 1722-1728
- 74 Baulac S, Lenk GM, Dufresnois B. et al. Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria. Neurology 2014; 82 (12) 1068-1075
- 75 Mirzaa GM, Rivière JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C (02) 122-130
- 76 Robin NH, Taylor CJ, McDonald-McGinn DM. et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A 2006; 140 (22) 2416-2425
- 77 Bahi-Buisson N, Poirier K, Boddaert N. et al. Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations. J Med Genet 2008; 45 (10) 647-653
- 78 Barkovich AJ. MRI analysis of sulcation morphology in polymicrogyria. Epilepsia 2010; 51 (0 1, Suppl 1): 17-22
- 79 Leventer RJ, Jansen A, Pilz DT. et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010; 133 (Pt 5): 1415-1427
- 80 Barkovich AJ. Current concepts of polymicrogyria. Neuroradiology 2010; 52 (06) 479-487
- 81 Takanashi J, Barkovich AJ. The changing MR imaging appearance of polymicrogyria: a consequence of myelination. AJNR Am J Neuroradiol 2003; 24 (05) 788-793
- 82 De Ciantis A, Barkovich AJ, Cosottini M. et al. Ultra-high-field MR imaging in polymicrogyria and epilepsy. AJNR Am J Neuroradiol 2015; 36 (02) 309-316
- 83 Stutterd CA, Dobyns WB, Jansen A. et al. Polymicrogyria overview. In: GeneReviews® [Internet]. Seattle, WA:: University of Washington, Seattle;; 1993
- 84 Chiaramonte R, Pavone P, Vecchio M. Speech rehabilitation in dysarthria after stroke: a systematic review of the studies. Eur J Phys Rehabil Med 2020; 56 (05) 547-562
- 85 Chiaramonte R, Vecchio M. Dysarthria and stroke. The effectiveness of speech rehabilitation. A systematic review and meta-analysis of the studies. Eur J Phys Rehabil Med 2021; 57 (01) 24-43
- 86 Chiaramonte R, Vecchio M. A systematic review of measures of dysarthria severity in stroke patients. PM R 2021; 13 (03) 314-324
- 87 Vecchio M, Gracies JM, Panza F. et al. Change in coefficient of fatigability following rapid, repetitive movement training in post-stroke spastic paresis: a prospective open-label observational study. J Stroke Cerebrovasc Dis 2017; 26 (11) 2536-2540
- 88 Cossu M, Pelliccia V, Gozzo F. et al. Surgical treatment of polymicrogyria-related epilepsy. Epilepsia 2016; 57 (12) 2001-2010
- 89 Maillard LG, Tassi L, Bartolomei F. et al. Stereoelectroencephalography and surgical outcome in polymicrogyria-related epilepsy: a multicentric study. Ann Neurol 2017; 82 (05) 781-794
- 90 Marciniak C, McAllister P, Walker H. et al; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Efficacy and safety of abobotulinumtoxinA (Dysport) for the treatment of hemiparesis in adults with upper limb spasticity previously treated with botulinum toxin: subanalysis from a phase 3 randomized controlled trial. PM R 2017; 9 (12) 1181-1190
- 91 Gracies JM, Jech R, Valkovic P. et al. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?. Brain Commun 2020; 3 (01) fcaa201
- 92 Floresta G, Patamia V, Gentile D. et al. Repurposing of FDA-approved drugs for treating iatrogenic botulism: a paired 3D-QSAR/docking approach† . ChemMedChem 2020; 15 (02) 256-262
- 93 Gentile D, Floresta G, Patamia V. et al. An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin A inhibitors. Int J Mol Sci 2020; 21 (24) 9470